Post-Approval Study of the Neuspera Sacral Neuromodulation System

Recruiting now · Not applicable

Conditions studied: Urinary Urgency Incontinence

In brief

Prospective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approval of the Neuspera SNM System. Participants in this study received intervention/implanted in Phase I or Phase II of the Neuspera SANS\_UUI (NSM-004) Study.

Key facts

Study ID
NCT07144813
Run by
Neuspera Medical, Inc.
People needed
116
Starts
2025-09-03
Expected to finish
2029-12-01
Last updated by the study team
2026-02-04

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.